RIA
CBPO

Realta Investment Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Realta Investment Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed -$12K – 1617
2019
Q4 		$12K Hold
100
– – ﹤0.01% 1098
2019
Q3 		$11K Hold
100
– – ﹤0.01% 1096
2019
Q2 		$10K Hold
100
– – ﹤0.01% 1158
2019
Q1 		$9K Buy
+100
New +$8.18K ﹤0.01% 948

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Realta Investment Advisors's CBPO Position: Q1 2020 in Review

Realta Investment Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2020, closing a stake of 100 shares — an estimated $12K sold.

Realta Investment Advisors first reported a position in CBPO in Q1 2019 and held it in 4 quarters. The position peaked at $12K in Q4 2019. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

  • Realta Investment Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 100 China Biologic Products Holdings, Inc. shares in Q1 2020, an estimated $12K.
  • Realta Investment Advisors first reported a position in China Biologic Products Holdings, Inc. in Q1 2019 and held it in 4 quarters.
  • Realta Investment Advisors's China Biologic Products Holdings, Inc. position peaked at $12K in Q4 2019.
  • 84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.